Cypre's blog to discuss the latest movements in science.
We presented a minisymposium talk alongside our collaborators at Genentech called “An in vitro 3D immune exclusion tumor model engineered in a layer-by-layer fashion”, highlighting our platform’s application in creating the immune excluded phenotype with mouse cells and assaying T cell infiltration through our ECM hydrogel, VersaGel®, and subsequent T cell-mediated killing.
Partner with Cypre to generate translational insights using our 3D tumor microenvironment organoid platform. From targeting the tumor or stroma, to modulating the immune system, we’re built for collaboration.
